Laboratorios Richmond S.A.C.I.F. (RICH.BA) Stock Analysis & Winston Score
Laboratorios Richmond is an Argentine pharmaceutical company that makes and sells medicines for people and animals. Its products include branded generic drugs — copies of well-known medicines sold under its own labels — covering areas like cardiology, diabetes, and infectious diseases. The company sells mainly to pharmacies, hospitals, and healthcare distributors across Argentina and other Latin American markets. Richmond earns money by manufacturing and selling these drugs directly, keeping a strong gross margin above 60% thanks to its own production facilities and established brand recognition in Argentina. The company operates primarily in Argentina, which makes it heavily exposed to that country's economic instability, including high inflation and currency controls that can erode real profits. Its main growth opportunity lies in expanding its product portfolio and increasing exports to neighboring countries, but Argentina's volatile macroeconomic environment remains the single biggest risk to its financial performance.
Winston Score: 38/100 — Below Average
Below-average fundamentals — multiple weak pillars.
- Quality: Mixed (9/30)
- Growth: Mixed (8/20)
- Cash Flow: Weak (0/10)
- Stability: Mixed (3/10)
- Valuation: Good (6/10)
- Ownership: Good (10/15)
Key Facts
Price: 1570.00 ARS
Market Cap: 126.8B ARS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Exchange: Buenos Aires Stock Exchange


